Kuo CF, Chou IJ, Rees F, Grainge MJ, Lanyon P, Davenport G, et al. Temporal relationships between systemic lupus erythematosus and comorbidities. Rheumatology (Oxford). 2019;58:840–8.

Article  PubMed  Google Scholar 

Kariniemi S, Rantalaiho V, Virta LJ, Kautiainen H, Puolakka K, Elfving P. Malignancies among newly diagnosed systemic lupus erythematosus patients and their survival. Lupus. 2022;31:1750–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Han J-Y, Cho S-K, Sung Y-K. Epidemiology of systemic lupus erythematosus in Korea. J Rheum Dis. 2023;30:211–9.

Article  PubMed  PubMed Central  Google Scholar 

Bernatsky S, Ramsey-Goldman R, Labrecque J, Joseph L, Boivin J-F, Petri M, et al. Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun. 2013;42:130-.

Article  PubMed  PubMed Central  Google Scholar 

Chen YJ, Chang YT, Wang CB, Wu CY. Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan. Am J Med. 2010;123(1150):e1-6.

Google Scholar 

Clarke AE, Pooley N, Marjenberg Z, Langham J, Nicholson L, Langham S, et al. Risk of malignancy in patients with systemic lupus erythematosus: systematic review and meta-analysis. Semin Arthritis Rheum. 2021;51:1230–41.

Article  PubMed  Google Scholar 

Zhang Y, Li W, Zhang P, Guo J, Sun J, Lu J, et al. Hematological malignancies in systemic lupus erythematosus: clinical characteristics, risk factors, and prognosis-a case-control study. Arthritis Res Ther. 2022;24:5.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Fallah M, Liu X, Ji J, Försti A, Sundquist K, Hemminki K. Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study. Ann Oncol. 2014;25:2025–30.

Article  PubMed  CAS  Google Scholar 

Mellemkjaer L, Andersen V, Linet MS, Gridley G, Hoover R, Olsen JH. Non-Hodgkin lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum. 1997;40:761–8.

Article  PubMed  CAS  Google Scholar 

Zard E, Arnaud L, Mathian A, Chakhtoura Z, Hie M, Touraine P, et al. Increased risk of high grade cervical squamous intraepithelial lesions in systemic lupus erythematosus: A meta-analysis of the literature. Autoimmun Rev. 2014;13:730–5.

Article  PubMed  Google Scholar 

Song L, Wang Y, Zhang J, Song N, Xu X, Lu Y. The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis. Arthritis Res Ther. 2018;20:270.

Article  PubMed  PubMed Central  Google Scholar 

Guo J, Ren Z, Li J, Li T, Liu S, Yu Z. The relationship between cancer and medication exposure in patients with systemic lupus erythematosus: a nested case-control study. Arthritis Res Ther. 2020;22:159.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bernatsky S, Ramsey-Goldman R, Joseph L, Boivin J-F, Costenbader KH, Urowitz MB, et al. Lymphoma risk in systemic lupus: effects of disease activity versus treatment. Ann Rheum Dis. 2014;73:138–42.

Article  PubMed  CAS  Google Scholar 

Löfström B, Backlin C, Sundström C, Ekbom A, Lundberg IE. A closer look at non-Hodgkin lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study. Ann Rheum Dis. 2007;66:1627–32.

Article  PubMed  PubMed Central  Google Scholar 

Han JY, Kim H, Jung SY, Jang EJ, Cho SK, Sung YK. Increased risk of malignancy in patients with systemic lupus erythematosus: population-based cohort study in Korea. Arthritis Res Ther. 2021;23:270.

Article  PubMed  PubMed Central  Google Scholar 

Cheol Seong S, Kim YY, Khang YH, Park JH, Kang HJ, Lee H, et al. Data Resource Profile: The National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2017;46:799–800.

PubMed  Google Scholar 

Kyoung DS, Kim HS. Understanding and Utilizing Claim Data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) Database for Research. J Lipid Atheroscler. 2022;11:103–10.

Article  PubMed  Google Scholar 

Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999–2001; first result using the national cancer incidence database. Cancer Res Treat. 2005;37:325–31.

Article  PubMed  PubMed Central  Google Scholar 

Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.

Article  PubMed  CAS  Google Scholar 

Bernatsky S, Ramsey-Goldman R, Foulkes WD, Gordon C, Clarke AE. Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis. Br J Cancer. 2011;104:1478–81.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kang KY, Kim HO, Yoon HS, Lee J, Lee WC, Ko HJ, et al. Incidence of cancer among female patients with systemic lupus erythematosus in Korea. Clin Rheumatol. 2010;29:381–8.

Article  PubMed  Google Scholar 

Bae EH, Lim SY, Han KD, Jung JH, Choi HS, Kim CS, et al. Systemic lupus erythematosus is a risk factor for cancer: a nationwide population-based study in Korea. Lupus. 2019;28:317–23.

Article  PubMed  CAS  Google Scholar 

Dreyer L, Faurschou M, Mogensen M, Jacobsen S. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term follow-up study in a Danish cohort. Arthritis Rheum. 2011;63:3032–7.

Article  PubMed  Google Scholar 

Wadström H, Arkema EV, Sjöwall C, Askling J, Simard JF. Cervical neoplasia in systemic lupus erythematosus: a nationwide study. Rheumatology (Oxford). 2017;56:613–9.

PubMed  Google Scholar 

Tam LS, Chan PK, Ho SC, Yu MY, Yim SF, Cheung TH, et al. Natural history of cervical papillomavirus infection in systemic lupus erythematosus - a prospective cohort study. J Rheumatol. 2010;37:330–40.

Article  PubMed  Google Scholar 

Klumb EM, Pinto AC, Jesus GR, Araujo M, Jascone J, Gayer CR, et al. Are women with lupus at higher risk of HPV infection? Lupus. 2010;19:1485–91.

Article  PubMed  CAS  Google Scholar 

Bruera S, Lei X, Zogala R, Pundole X, Zhao H, Giordano SH, et al. Cervical cancer screening in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2021;73:1796–803.

Article  PubMed  Google Scholar 

Antonelli A, Mosca M, Fallahi P, Neri R, Ferrari SM, D’Ascanio A, et al. Thyroid cancer in systemic lupus erythematosus: a case-control study. J Clin Endocrinol Metab. 2010;95:314–8.

Article  PubMed  CAS  Google Scholar 

Cao L, Tong H, Xu G, Liu P, Meng H, Wang J, et al. Systemic lupus erythematosus and malignancy risk: a meta-analysis. PLoS ONE. 2015;10:e0122964.

Article  PubMed  PubMed Central  Google Scholar 

Navarro Silvera SA, Miller AB, Rohan TE. Risk factors for thyroid cancer: a prospective cohort study. Int J Cancer. 2005;116:433–8.

Article  PubMed  Google Scholar 

Miller FW, Moore GF, Weintraub BD, Steinberg AD. Prevalence of thyroid disease and abnormal thyroid function test results in patients with systemic lupus erythematosus. Arthritis Rheum. 1987;30:1124–31.

Article  PubMed  CAS  Google Scholar 

Klionsky Y, Antonelli M. Thyroid disease in Lupus: an updated review. ACR Open Rheumatol. 2020;2:74–8.

Article  PubMed  PubMed Central  Google Scholar